Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition

Published:2017-04 Issue: Volume:55 Page:83-95
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Facchinetti Francesco,Rossi Giulio,Bria Emilio,Soria Jean-Charles,Besse Benjamin,Minari Roberta,Friboulet Luc,Tiseo Marcello

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference132 articles.

1. Rare cancers: a sea of opportunity;Boyd;Lancet Oncol,2016

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. ROS1 rearrangements define a unique molecular class of lung cancers;Bergethon;J Clin Oncol,2012

4. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer;Davies;Clin Cancer Res,2012

5. ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability;Scheffler;Oncotarget,2015

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives;Frontiers in Oncology;2024-07-11

2. Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2024

3. Effectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer: real-world evidence in Japan;Future Oncology;2023-12

4. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2023-09-28

5. Comparison of Different ROS1 Immunohistochemistry Clones and Consistency with Fluorescence In Situ Hybridization Results in Non-Small Cell Lung Carcinoma;Balkan Medical Journal;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3